Treatment of extranodal lymphomas

被引：28

作者：

Zucca, E ^{[1
]}

Conconi, A

Cavalli, F

机构：

[1] Osped San Giovanni Bellinzona, Oncol Inst So Switzerland, Int Extranodal Lymphona Study Grp, CH-6500 Bellinzona, Switzerland

[2] Amedeo Avogradro Univ Eastern Piedmont, Azienda Ospedaliera Maggiore della Carita, Div Internal Med, Ctr Study & Treatment Blood Disorders, I-28100 Novara, Italy

来源：

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2002年 / 15卷 / 03期

关键词：

non-Hodgkin's lymphoma; extranodal; therapy; MALT lymphoma; angiocentric T/NKlymphoma; mycosis fungoides; stomach; skin; CNS; testis;

D O I：

10.1053/beha.2002.0218

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

At least one-quarter of the non-Hodgkin's lymphomas arise primarily at extranodal sites. The rising incidence of non-Hodgkin's lymphomas, observed over recent decades, have mainly affected the primary extranodal entities. Survival rates vary among the specific sites of primary extranodal lymphomas. This is due partly to differences in natural history, related mainly to the histological type but also to differences in management strategy which are related to organ-specific problems. Few controlled studies facilitate therapeutic decisions in this setting. This chapter represents a general overview of the available data.

引用

页码：533 / 547

页数：15

共 96 条

[1] Long-term survival in primary CNS lymphoma [J].

Abrey, LE ;

DeAngelis, LM ;

Yahalom, J .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :859-863

[2] Treatment for primary CNS lymphoma: The next step [J].

Abrey, LE ;

Yahalom, J ;

DeAngelis, LM .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3144-3150

[3]

ABREY LE, 2001, P AM SOC CLIN ONCO A, V53

[4] Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial [J].

Bertoni, F ;

Conconi, A ;

Capella, C ;

Motta, T ;

Giardini, R ;

Ponzoni, M ;

Pedrinis, E ;

Novero, D ;

Rinaldi, P ;

Cazzaniga, G ;

Biondi, A ;

Wotherspoon, A ;

Hancock, BW ;

Smith, P ;

Souhami, R ;

Cotter, FE ;

Cavalli, F ;

Zucca, E .

BLOOD, 2002, 99 (07) :2541-2544

[5] High-dose methotrexate for the treatment of primary cerebral lymphomas: Analysis of survival and late neurologic toxicity in a retrospective series [J].

Blay, JY ;

Conroy, T ;

Chevreau, C ;

Thyss, A ;

Quesnel, N ;

Eghbali, H ;

Bouabdallah, R ;

Coiffier, B ;

Wagner, JP ;

Le Mevel, A ;

Dramais-Marcel, D ;

Baumelou, E ;

Chauvin, F ;

Biron, P .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :864-871

[6] ROLE OF HELICOBACTER-PYLORI ERADICATION IN HIGH-GRADE MALT LYMPHOMA [J].

BOOT, H ;

DEJONG, D ;

VANHEERDE, P ;

TAAL, B .

LANCET, 1995, 346 (8972) :448-449

[7] Risk of non-Hodgkin lymphoma in celiac disease [J].

Catassi, C ;

Fabiani, E ;

Corrao, G ;

Barbato, M ;

De Renzo, A ;

Carella, AM ;

Gabrielli, A ;

Leoni, P ;

Carroccio, A ;

Baldassarre, M ;

Bertolani, P ;

Caramaschi, P ;

Sozzi, M ;

Guariso, G ;

Volta, U ;

Corazza, GR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11) :1413-1419

[8]

Cavalli F, 2001, Hematology Am Soc Hematol Educ Program, P241

[9] Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma [J].

Cellier, C ;

Delabesse, E ;

Helmer, C ;

Patey, N ;

Matuchansky, C ;

Jabri, B ;

Macintyre, E ;

Cerf-Bensussan, N ;

Brousse, N .

LANCET, 2000, 356 (9225) :203-208

[10] KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-RELATED BODY-CAVITY-BASED LYMPHOMAS [J].

CESARMAN, E ;

CHANG, Y ;

MOORE, PS ;

SAID, JW ;

KNOWLES, DM .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18) :1186-1191

← 1 2 3 4 5 6 7 8 9 10 →